The future of NGS in cancer looks promising with advancements in technology and analysis methods. Emerging areas include single-cell sequencing, which allows for the analysis of genetic material at the individual cell level, providing deeper insights into tumor heterogeneity and evolution. Additionally, integration with other 'omics' technologies, such as proteomics and metabolomics, will offer a more comprehensive understanding of cancer biology.
